Alliance Clinical Research   Report issue

For profit Phase 3
Founded: Jacksonville FL United States (2002)

Organization Overview

First Clinical Trial
2010
NCT01354717
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Alliance Clinical Research, Inc

Active Ingredients

Drugs in Phase 3 Trials (2)

diclofenac (voltaren) (2 trials)

fluorouracil (efudex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Keratosis (Phase 3)

Keratosis, Actinic (Phase 3)

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2